Hypertrophic cardiomyopathy, or obstructive HCM, is a genetic condition where the heart muscle becomes thick, making it harder for blood to pump.
MedPage Today on MSN
What Are the Goalposts for Present and Future ATTR-CM Therapies?
With several disease-modifying therapies available for transthyretin amyloid cardiomyopathy (ATTR-CM) -- and more waiting in ...
One study examines the small molecular cardiac myosin inhibitor for safety and efficacy at 96 weeks, and another compares it ...
The Genetic Cardiomyopathy Awareness Consortium, which is part of the DCM Foundation, announced the launch of the Genetic Cardiomyopathy Patient Registry during a webinar on January 22, 2025. The ...
SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a collaboration with the Hypertrophic Cardiomyopathy Association ...
The designation honors members of the AHA and American Stroke Association who have made extraordinary contributions to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback